Tag: big pharma

NewsGuard fact-checked me today, providing the opportunity to clarify questions about the Audenz vaccine and the extremely high mortality rate in its small trial.

The big guns, the Health Editor, approached me this afternoon. Happy to learn the presentation is getting attention.

Below is the email I received and below that is my detailed reply.

On Jul 3, 2024, at 1:26 PM, John Gregory <john.gregory@newsguardtech.com> wrote:

Dr. Nass, 

My name is John Gregory, health editor at NewsGuard. We’re a news organization that reports on and tracks online misinformation. 

I’m emailing in regards to your April 20, 2024, CHD video in which you cited the FDA package insert for the H5N1 vaccine Audenz, and said, “One in 200 people who got this vaccine in a clinical trial died,” and later added, “This is a dangerous vaccine for a nothing disease.”

Video of your remarks has begun circulating widely on social media platforms in the past two weeks, used as evidence for claims like “Dr. Meryl Nass: One of the approved Bird Flu quackccines, Audenz… had a death rate of 1 in 200 during clinical trials.” 

I noticed the screenshot included in your original video highlighted the sentence, ““Fatal SAEs [Serious Adverse Events] included 11 (0.5%) Audenz recipients and 1 (0.1%) placebo recipients,” even though the very next sentence said, ““No SAEs were assessed as being related to Audenz,” meaning that none of the reported serious adverse events – including deaths – that occurred among trial participants were caused by the vaccine.

You also did not mention that the FDA’s own statistical review of Audenz stated that, “No deaths occurred that were considered related to the vaccine,” and concluded, “No major statistical or safety issues have been identified” with the vaccine, or that the published results of the Audenz trial said:

None of the serious AEs or AEs of special interest reported by subjects who received aH5N1c were considered vaccine related. Two subjects in the placebo group reported a related AE of special interest (immune thrombocytopenic purpura and polymyalgia rheumatic); these events were also considered serious AEs. During the study, 12 (0.4%) subjects had serious AEs with a fatal outcome, none of which were attributed to the study treatment, and most (n = 11) occurred after Day 43 during the follow-up period in subjects ≥65 years with underlying severe comorbidities and multiple concomitant medications.

Is there any reason why you did not mention any of this countervailing information?

My deadline is 5pm eastern today, July 3. Thank you. 

— 

Best regards, 
John Gregory

john.gregory@newsguardtech.com

Office: ‪(312) 489-8676

More about NewsGuard criteria here.

Dear Mr. Gregory,

Since I provided a screenshot of the package insert of the Audenz licensed vaccine and repeated what it said, this can hardly be characterized as misinformation, which you claim to be investigating.  Since I included the next sentence in the presentation, it cannot even be construed as incomplete.

Had you been working on issues of vaccines for over 25 years as I have, you would have been aware that the sponsor (mfr) and FDA, who together craft the vaccine labels aka package inserts, ALWAYS assert that most or all of the deaths and serious adverse events occurring during a clinical trial were adjudged to be not due to the vaccine.  Had they judged otherwise, a license would probably not have been issued.  A license was issued for Audenz.

Later, when a vaccine is given to millions of people, not just a few hundred as in this case, one learns which side effects are IN FACT attributable to the vaccine.

For example, at least a hundred million Americans had received an mRNA COVID vaccine before it was determined to cause myocarditis, in late May of 2021 by FDA.

That is the reason why the raw data, which I presented, are important.  So that people have the information to judge for themselves what risks they may face when choosing vaccination.  In fact, clinical trials often exclude sick subjects, and drugs and vaccines almost invariably appear more safe and effective in clinical trial data than they do later, in the real world—a fact known to all medical researchers.

Why did I not mention material from an article?  Because I was referring to the Audenz label, which is the legal document that FDA attests is true, unlike published articles which are generally written by the vaccine sponsor and have a lesser degree of reliability.  In fact, the numbers in the article versus those in the label are not exactly the same.

Furthermore, if the US government was comfortable with the H5N1 Audenz vaccine, why did DHHS’ BARDA just place an order with Moderna for H5N8 mRNA vaccines, even though the avian flu circulating in the US is H5N1?  Even though it makes much more sense to match the neuraminidase portion of the vaccine to the circulating strain…  which is done every year when seasonal influenza vaccines are produced?

Finally, I invite you to take a look at the WHO data on deaths in humans worldwide from the H5N1 bird flu, which confirms it is a nothing disease in humans, having mutated to a different form than it once had.  The federal health agencies have monitored 9,000 farm workers and all they found were 4 mild cases of disease, no hospitalizations and no deaths in the US over the past several years.

Keep reading

U.S. Will Pay Moderna $176 Million to Develop mRNA Bird Flu Vaccine

The United States government will pay vaccine manufacturer Moderna $176 million to develop a new mRNA vaccine to treat bird flu.

The U.S. Department of Health and Human Services will pay Moderna $176 million for a vaccine containing the same mRNA technology as the company’s COVID-19 vaccine.

Bird flu, or H5N1, has been reported in dairy cows and has infected three people in the United States.

In total, 135 dairy herds have been infected with bird flu in 12 states.

Per AP:

The U.S. government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country, federal officials announced Tuesday.

The funds are targeted for release through the U.S. Department of Health and Human Services and will pay for continued development of a vaccine that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19. The award was made through the Biomedical Advanced Research and Development Authority, or BARDA, a program focusing on medical treatments for potential pandemics.

Keep reading

Pandemic Preparedness: Arsonists Run the Fire Department

Imagine if you will, an exceptionally ambitious city Fire Department, located in a city with very few naturally occurring fires.

These ambitious firemen don’t have nearly enough work, prestige, or pay for their liking. Uninterested in simply polishing their trucks, lifting weights, and cooking chili, these firemen want more. A lot more.

They construct a plan. They will start a research program, funded by taxpayers, whereby they will develop an arsenal of the biggest, scariest, most flammable products on earth. They will justify this program under the pretense that these destructive creations are absolutely necessary for the development of bigger and better fire extinguishers. Incidentally, they will also develop, market, and sell these fire extinguishers themselves.

These proprietary fire extinguishers will net the ambitious firemen an incredible fortune – if they can just get every man, woman, and child in the city to buy one.

The Fire Department, working with the corporations that would manufacture their miracle extinguishers, actively publicizes the supposedly tremendous, ever-increasing risk of fires that they claim threaten the population. According to the ambitious firemen, risk factors for worsened fires are everywhere and are ever-increasing – global warming, population growth, take your pick – and the next “big one” is just around the corner. 

Credulous, fearful citizens and heavily lobbied politicians fall for their story, pumping ever more tax dollars into the Fire Department’s research and development program.

The Fire Department develops and grows its stockpile of manufactured fire super-hazards, until one day…

OOPS! 

Somehow, one of the flammable products is released, and a raging conflagration ensues. No one knows exactly how it started – in fact, the chief firemen gather together and publicly deny that any of their products could be responsible. 

But by terrifying the public and confusing the politicians, the firemen coerce the population to shelter in place and follow their strict instructions, lest they perish in the holocaust. After all, the firemen are the experts. 

They heavily promote their special fire extinguishers as the only solution, even managing to get water outlawed for firefighting purposes! (Water wouldn’t work on this kind of fire, they insist. Only the Fire Department’s special extinguishers will suffice.)

Using a huge injection of taxpayer funds, the Fire Department gets their fire extinguishers built in record time, and they hard-sell them to everyone they possibly can. In the meantime, large swaths of the city burn to the ground. And due to the fire extinguishers’ poor design and hasty construction, these devices turn out to be every bit as deadly as the fire, if not worse, for their damaging effects linger long after the fire has burned itself out.

But the firemen and their corporate cronies have secured their fortunes.

The bewildered, traumatized population can’t figure out what happened, any more than the feckless politicians. The Fire Department emerges as the most powerful entity in the city. They resume their “research,” fortified by their growing wealth and power. 

After all, the next big conflagration is just around the corner.

Sound implausible? Think again. Because in the realm of “pandemic preparedness,” the arsonists are running the Fire Department.

Keep reading

Pfizer purchased companies that produce drugs to treat the same conditions caused by covid vaccines

In 2017 a former vice president of Pfizer blew the whistle and said that pharmaceutical companies intentionally design vaccines to keep the public in a state of illness to profit from the treatments of vaccine-induced illnesses. 

Pfizer’s acquisitions of other pharmaceutical companies since the rollout of its covid vaccine seem to indicate this is indeed the case.

In 2021, Pfizer’s acquisition of Arena Pharmaceuticals raised eyebrows. The purchase price seemed disproportionate to the market size of the drug they acquired – a drug that is a potential therapy for all kinds of immuno-inflammatory diseases, including inflammation of the heart.  As we know, myocarditis began to skyrocket after the rollout of Pfizer’s mRNA vaccines.

In 2023, Pfizer purchased Seagen Pharmaceuticals, known for its cancer drugs.  Was this because of the connection between the mRNA injections and “turbo cancers”?

In 2022, Pfizer purchased Global Blood Therapeutics for its drug to treat sickle cell disease, again for an amount that seemed disproportionate to the profit the company could make off the drug considering how many people have the disease.  Does Pfizer know something we don’t? Will we see a blood cell disease epidemic as well?

Keep reading

4 More U.S. States Sue Pfizer Over False COVID Vaccine Claims

Four additional states will follow Kansas’s lead by filing large-scale lawsuits against pharmaceutical giant Pfizer. These states allege that the company misled the public regarding the safety and efficacy of its COVID-19 vaccine.

Last week, Kansas Attorney General Kris Kobach announced that he is suing pharmaceutical giant Pfizer for misleading Kansas residents about the safety and efficacy of its COVID-19 vaccine.

During a press conference in Topeka, alongside Deputy Attorney General Fran Oleen and Assistant Attorneys General Kaley Schrader and Melanie Jack, Kobach detailed the allegations lodged against Pfizer.

“Kansas is filing a civil suit against the Pfizer Corporation under the Kansas Consumer Protection Act, seeking enhanced civil monetary penalties, damages, and injunctive relief for misleading and deceptive statements made in marketing its COVID-19 vaccine. Pfizer also violated previous consent judgments with the state of Kansas, in which Pfizer promised never to use deceptive information to market their products,” said Kobach.

The complaint, lodged today in Thomas County District Court, accuses Pfizer of misleading Kansans about the vaccines’ risks, including potential harm to pregnant women and the risk of myocarditis. The suit further alleges that Pfizer falsely claimed its vaccine was effective against COVID variants, despite evidence to the contrary.

Keep reading

Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial

Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1

GBS is a “polio-like” inflammatory autoimmune disorder in which a person’s immune system damages nerve cells, which can result in muscle weakness and paralysis of the face, respiratory system and limbs, including full body paralysis and can lead to death. GBS usually develops after an infection and symptoms include numbness and tingling, throbbing pain, heart rhythm problems, high blood pressure, slurred speech, difficulty swallowing and shortness of breath. Most people recover but, in some cases, the nerve damage is permanent.2

Current recommendations state that patients over the age of 60 should talk to their doctor to decide whether they should get the new RSV vaccine. Government officials still say that the benefits of the vaccine outweigh the risks and that they do not plan to change their recommendations.1

The most recent CDC report highlighted 28 cases of RSV vaccine-related GBS and all but one developed symptoms of GBS within 21 days after being vaccinated. Data from the Vaccine Adverse Event Reporting System (VAERS) revealed that there were 1.5 cases per one million in people who received GlaxoSmithKline’s (GSK) Arexvy RSV vaccine, and five cases per one million in people who received Pfizer’s Abrysvo RSV vaccine.

There were 18 reported deaths after RSV vaccinations that were attributed to “a variety of reasons,” two of which were associated with GBS. Other reported causes of death included severe respiratory illness and failure, cardiovascular events, hepatic encephalopathy, RSV infection, and sepsis, among others.3

Keep reading

17 Drugs Most Potentially Toxic to the Liver Identified: UPenn Study

Researchers identified 17 most potentially liver-toxic drugs in a Monday study published in JAMA Internal Medicine.

The study authors said they ranked the drugs according to the rates of severe liver injury, though they could not determine if the 17 drugs caused the acute injury in every event.

According to their findings, 11 of the 17 drugs identified may have wrongly received a lower hepatotoxicity (potential to harm the liver) rank according to the current ranking system.

To establish drugs’ potential for liver toxicity, researchers have used case reports of liver toxicity listed on the National Institutes of Health LiverTox website. Case reports are detailed reports on an individual patient; they often describe a novel or unusual patient case. Doctors write case reports when encountering a unique or novel patient presentation in their clinics. Some doctors write case reports, and others do not.

This “undoubtedly leads to underreporting,” senior author Dr. Vincent Lo Re, III, associate professor of medicine and epidemiology at the University of Pennsylvania, told The Epoch Times.

Because the drug rankings are based on voluntary clinician reporting instead of large population studies, the toxicity profile of some drugs may be missed if the clinician does not publish a case report.

Keep reading

Pfizer CEO says ‘anti-science disinfo’ could cause another HOLOCAUST, compares Pfizer and elite establishment to the Jews

The Holocaust happened because powerful elites spread disinformation framing a small minority as vectors for disease to justify extreme segregation policies, leading eventually to the Final Solution.1

Somehow, Pfizer CEO Dr Albert Bourla thinks Pfizer are the Jews in this analogy.

In a talk on 31 January 2023 for Duke University’s Fuqua Business School, Bourla said that disinformation is “the worst thing that I have seen during this pandemic,” before going on to liken independent scientists questioning “the science” to Goebbels spreading disinformation about the Jews. He warned that if this “anti-science” disinformation continues to spread on social media, we may have another Holocaust.

ALT: ‘If you question our PR campaign and don’t keep up demand for our commercial products (all paid for with your tax dollars) you’re basically a Nazi’

Bourla’s statement as follows (emphasis mine):

“[Disinformation is] the worst thing that I have seen during this pandemic, and that is my worst experience. I’m not speaking about misinformation, which is information that is wrong, but can be innocent. The people that are spreading it, they don’t know what they are talking about, they don’t know better. I’m talking about disinformation. Willingly, knowingly spreading malicious information that usually tries to appeal to the most basic instincts of people that could be fear, xenophobia, which could be any of those things, and clearly anti-science, and is focussing now on the science.”

Keep reading

Big Pharma’s supply chain is CRUMBLING as drug shortages reach decade high

The United States Pharmacopeia, an independent, science-based nonprofit, released its first annual Drug Shortage Report (USP) showing that drug shortages are currently at the highest level in a decade with 2023 marking the worst year yet.

Over the past 10 years, the number of drug shortages has increased dramatically, the report explains, with 125 active drug shortages monitored by the U.S. Food and Drug Administration (FDA) at the end of 2023.

“This high number of shortages is a direct result of persistent market vulnerabilities,” the report states. “According to our analysis, over a quarter of drugs in shortage were new drug shortages (34 products) in 2023.”

Published in early June, the report explains that the average drug shortage lasts more than three years and impacts multiple types of drugs. One in four drug shortages lasted more than five years while six drugs, including epinephrine injections for serious allergic reactions, has been in low supply for a decade. More than half of all new drug shortages involve injectable generic medications.

“Unexpected shocks can break the system and disrupt the supply of quality medicines,” said Anthony Lakavage, senior vice president for Global External Affairs at USP, a nonprofit organization that sets global quality standards for medications, dietary supplements and food ingredients.

“This worrisome trajectory leads to more frequent drug shortages, prolonged scarcity, and more people at risk of not getting the medicines they need, when they need them.”

(Related: Pharmaceutical drug manufacturing has degraded so badly with so many contamination problems that the Department of Defense [DoD] has intervened to call for outside testing.)

Keep reading

CDC STACKS ITS VACCINE COMMITTEE WITH PHARMA-AFFILIATED MEMBERS AHEAD OF JUNE 2024 VOTE ON COVID-19 VACCINES

An ICAN investigation into the background of new members appointed to CDC’s highly influential Advisory Committee for Immunization Practices (ACIP) reveals deep ties with the pharmaceutical industry. Later this month, ACIP will vote on COVID-19 vaccine recommendations for the 2024-25 season. In May, ICAN filed a lawsuit against HHS for its failure to comply with a FOIA request related to these ACIP appointments.

Recently, the Department of Health and Human Service (HHS) announced that it had finally filled eight vacant positions and added an additional voting member to ACIP (which advises CDC on which vaccines should be administered within the United States, how often, and to whom), bringing the number to sixteen voting members.

Given that half of the committee is being replaced at once, ICAN submitted FOIA requests seeking more information on these appointments and, when HHS failed to respond in accordance with the law, ICAN brought suit. In the meantime, ICAN conducted its own investigation and, disturbingly, found that seven of these nine individuals have direct financial ties to vaccine manufacturers, and many have received multi-million dollar grants from NIH.

Keep reading